Drug-eluting stent

Original Contribution

Outcomes Following Coronary Chronic Total Occlusion Revascularization With Drug-Coated Balloons

02/21/2024

Yuan Zhi , MD;

Vanessa Bade , BSc;

Adrian Attinger-Toller , MD;

Florim Cuculi , MD;

Irena Majcen , PhD;

Mathias Wolfrum , MD;

Stefan Toggweiler , MD;

Giacomo M. Cioffi , MD;

Federico Moccetti , MD;

Francesco Ferraro , MD;

Mehdi Madanchi , MD;

Eleonora Gnan , MD;

Matthias Bossard , MD;

Varis Gjergjizi , MD;

The study aimed to describe the safety and long-term outcomes of patients with coronary chronic total occlusions undergoing percutaneous coronary interventions with the latest generation of drug-coated balloons vs novel drug-eluting stents.

The study aimed to describe the...

02/21/2024

Journal of Invasive Cardiology

Editor's Message

Editor's 2023 Top 10

02/07/2024

Deepak L. Bhatt , MD, MPH, FACC, FAHA, FESC, MSCAI;

Dr Deepak L. Bhatt, Editor-in-Chief of JIC, presents the Top 10 articles from 2023.

Dr Deepak L. Bhatt,...

02/07/2024

Journal of Invasive Cardiology

Giannopoulos Drug-Eluting Stent Figure 1

Original Contribution

Concomitant Drug-Coated Balloon Angioplasty With Bail-Out Use of Eluvia Drug-Eluting Stent: Is There Any Downside to a Double Dose of Paclitaxel?

06/01/2022

Eric A. Secemsky , MD, MSc, RPVI, FACC, FAHA, FSCAI;

Ehrin J. Armstrong , MD, MSc, FACC;

Stefanos Giannopoulos , MD;

The application of 2 distinct and simultaneously applied drug-delivery platforms for the treatment of peripheral artery disease has not been studied. This study investigated the outcomes of femoropopliteal disease treated with drug-coated...

The application of 2 distinct...

06/01/2022

Journal of Invasive Cardiology

Original Contribution

Alex Plus Versus Xience Drug-Eluting Stents for Percutaneous Coronary Intervention in Routine Clinical Practice: A Propensity Score-Matched Analysis

04/01/2022

Arturo Giordano , MD, PhD;

Nicola Corcione , MD;

Paolo Ferraro , MD;

Giuseppe G.L. Biondi-Zoccai , MD, PhD;

Martino Pepe , MD, PhD;

Palma Luisa Nestola , MD;

Alberto Morello , MD;

Michele Cimmino , MD;

Michele Albanese , MD;

Salvatore Giordano , MD;

The next iteration of drug-eluting stents (DESs) for percutaneous coronary intervention (PCI) has focused on bioresorbable polymers and thin struts. The Alex Plus DES is a new-generation sirolimus-eluting device with 70 µm cobalt chromium...

The next iteration of...

04/01/2022

Journal of Invasive Cardiology

Original Contribution

Two-Year Clinical Outcomes of the REVELATION Study: Sustained Safety and Feasibility of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent in Acute Myocardial Infarction

01/03/2022

Sander R. Niehe , MD;

René J. Van Der Schaaf , MD, PhD;

Jean-Paul R. Herrman , MD, PhD;

Nicola S. Vos , MD;

Mark S. Patterson , MBBS, PhD, MD, MRCP;

Ton Slagboom , MD;

Giovanni Amoroso , MD, PhD;

Maarten A. Vink , MD, PhD;

The randomized REVELATION trial showed that in the setting of STEMI, a drug-coated balloon strategy was non-inferior to a drug-eluting stent strategy in terms of fractional flow reserve assessed at 9 months. The aim of the present study is to...

The randomized REVELATION trial...

01/03/2022

Journal of Invasive Cardiology

Clinical Images

Unstable Angina Induced by Fracture of a Recently Implanted Drug-Eluting Stent

01/03/2022

Stergios Soulaidopoulos , MD, PhD;

Konstantinos Aznaouridis , MD, PhD;

Dimitris Karlis , MD, PhD;

Konstantinos Tsioufis , MD, PhD;

IVUS is extremely useful to confirm the diagnosis and identify the possible mechanism of the stent fracture, as well as to assess the final result after subsequent angioplasty.

IVUS is extremely useful to...

01/03/2022

Journal of Invasive Cardiology

Optical coherence tomography images after first-generation drug-eluting stent implantation

Original Contribution

Atherogenesis in Native Coronary Segments and In-Stent Neoatherogenesis Beyond Three Years After First-Generation Drug-Eluting Stent Implantation: Angiographic and Optical Coherence Tomography Study

09/01/2021

Dorota Ochijewicz , MD;

Lukasz Kołtowski , MD, PhD;

Janusz Kochman , MD, PhD;

Mariusz Tomaniak , MD, PhD;

Piotr Barus , MD;

Adam Rdzanek , MD, PhD;

Arkadiusz Pietrasik , MD, PhD;

Grzegorz Opolski , MD, PhD;

This study investigates the association between subclinical in-stent neoatherosclerosis and atherosclerosis progression of native coronary segments in patients with chronic coronary syndrome.

This study investigates the...

09/01/2021

Journal of Invasive Cardiology

Original Contribution

Outcomes of Vascular Closure Device Use After Transfemoral Coronary Intervention: Insights From the EXCEL Trial

08/01/2021

Paul Guedeney , MD;

Joseph F. Sabik III, MD;

Charles A. Simonton III, MD;

Zixuan Zhang , MS;

Ovidiu Dressler , MD;

Arie Pieter Kappetein , MD, PhD;

Gregg W. Stone , MD, FACC, FSCAI;

Patrick W. Serruys , MD, PhD;

David E. Kandzari , MD;

Marie-Claude Morice , MD, FESC, FACC;

Roxana Mehran , MD;

Toshiki Kuno , MD, PhD;

Ori Ben-Yehuda , MD;

Bimmer E.P.M. Claessen , MD, PhD;

The study objective is to assess the safety and efficacy of using vascular closure devices in percutaneous coronary intervention for left main coronary artery disease.

The study objective is to assess...

08/01/2021

Journal of Invasive Cardiology

Original Contribution

Percutaneous Coronary Intervention for Very Small Vessels With the Use of a Newer-Generation 2.0 mm Drug-Eluting Stent

06/29/2021

Yao-Chang Wang , MD;

Tien-Ping Tsao , MD;

Wei-Hsian Yin , MD, PhD;

Hsu-Lung Jen , MD, PhD;

The outcomes of treating coronary artery disease (CAD) in very small vessels

The outcomes of treating...